Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Texas Heart Institute/St. Luke's Episcopal Hospital/Baylor College
mi
from
Houston, TX
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Texas Heart Institute/St. Luke's Episcopal Hospital/Baylor College
mi
from
Houston, TX
Click here to add this to my saved trials
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
University of Virginia Health System
mi
from
Charlottesville, VA
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Medical University Innsbruck
mi
from
Innsbruck,
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Medical University Innsbruck
mi
from
Innsbruck,
Click here to add this to my saved trials
Hypovitaminosis D in Neurocritical Patients
Randomized Clinical Trial of Hypovitaminosis D Treatment in the Neurocritical Care Unit
Status: Enrolling
Updated:  12/31/1969
University Of Utah Hospital
mi
from
Salt Lake City, UT
Hypovitaminosis D in Neurocritical Patients
Randomized Clinical Trial of Hypovitaminosis D Treatment in the Neurocritical Care Unit
Status: Enrolling
Updated: 12/31/1969
University Of Utah Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Oracle Research
mi
from
Huntsville, AL
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Oracle Research
mi
from
Huntsville, AL
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
USC Medical Center
mi
from
Los Angeles, CA
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
University Hospital
mi
from
Augusta, GA
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
University Hospital
mi
from
Augusta, GA
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospital and Clinics
mi
from
Iowa City, IA
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospital and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Medical Research Institute, Inc
mi
from
Slidell, LA
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Medical Research Institute, Inc
mi
from
Slidell, LA
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Baystate Medical Center-Cardiology Section
mi
from
Springfield, MA
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Baystate Medical Center-Cardiology Section
mi
from
Springfield, MA
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Elmhurst Hospital Center
mi
from
Elmhurst, NY
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Elmhurst Hospital Center
mi
from
Elmhurst, NY
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Columbia Presbyterian Medical Center-Heart Failure Center
mi
from
New York, NY
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Columbia Presbyterian Medical Center-Heart Failure Center
mi
from
New York, NY
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine - Texas Medical Center
mi
from
Houston, TX
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine - Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Alfred Hospital, Monash University, Central and Eastern School
mi
from
Prahran,
Tezosentan in the Treatment of Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Alfred Hospital, Monash University, Central and Eastern School
mi
from
Prahran,
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Advanced Heart Failure and Transplant Service, Palo Alto VA Health Care System, Cardiology Section
mi
from
Palo Alto, CA
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Advanced Heart Failure and Transplant Service, Palo Alto VA Health Care System, Cardiology Section
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Denver VAMC
mi
from
Denver, CO
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Denver VAMC
mi
from
Denver, CO
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
The Heart Hospital at Alledgheny General, Division of Cardiology
mi
from
Pittsburgh, PA
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
The Heart Hospital at Alledgheny General, Division of Cardiology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Veterans Affairs Medical Center
mi
from
Houston, TX
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Veterans Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Tyler Cardiovascular Consultants
mi
from
Tyler, TX
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Tyler Cardiovascular Consultants
mi
from
Tyler, TX
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Danville Medical Center
mi
from
Danville, VA
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Danville Medical Center
mi
from
Danville, VA
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
Medical Associates, Bellebue
mi
from
Bellevue, WA
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
Medical Associates, Bellebue
mi
from
Bellevue, WA
Click here to add this to my saved trials
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated:  12/31/1969
AKH University of Vienna, Abt. Medizinische Kardiologie
mi
from
Vienna,
Tezosentan in Acute Heart Failure
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.
Status: Enrolling
Updated: 12/31/1969
AKH University of Vienna, Abt. Medizinische Kardiologie
mi
from
Vienna,
Click here to add this to my saved trials
Partnering Physical and Emotional Fitness: Improving Cardiac Recovery With Training in Emotion Regulation
Partnering Physical and Emotional Fitness: Improving Cardiac Recovery With Training in Emotion Regulation
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Partnering Physical and Emotional Fitness: Improving Cardiac Recovery With Training in Emotion Regulation
Partnering Physical and Emotional Fitness: Improving Cardiac Recovery With Training in Emotion Regulation
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Status: Enrolling
Updated:  12/31/1969
Oklahoma Cardiovascular Research
mi
from
Oklahoma City, OK
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Status: Enrolling
Updated: 12/31/1969
Oklahoma Cardiovascular Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Status: Enrolling
Updated:  12/31/1969
Sentara Cardiovascular
mi
from
Norfolk, VA
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
Status: Enrolling
Updated: 12/31/1969
Sentara Cardiovascular
mi
from
Norfolk, VA
Click here to add this to my saved trials
SGLT2 Inhibition in Diabetes and Heart Failure
SGLT2 Inhibition in Diabetic Patients With Heart Failure With Reduced Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
SGLT2 Inhibition in Diabetes and Heart Failure
SGLT2 Inhibition in Diabetic Patients With Heart Failure With Reduced Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Arizona College of Medicine
mi
from
Tucson, AZ
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Arizona College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Evanston Northshore Healthcare
mi
from
Evanston, IL
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Evanston Northshore Healthcare
mi
from
Evanston, IL
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
St. Vincent's
mi
from
Indianapolis, IN
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
St. Vincent's
mi
from
Indianapolis, IN
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Institute of the South
mi
from
Houma, LA
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Institute of the South
mi
from
Houma, LA
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Ochsner Clinic Foundation
mi
from
New Orleans, LA
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
St. Luke's
mi
from
Kansas City, MO
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
St. Luke's
mi
from
Kansas City, MO
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center/ NewYork Presbyterian Hospital
mi
from
New York, NY
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center/ NewYork Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Mt Sinai Hospital
mi
from
New York, NY
REDUCE LAP-HF RANDOMIZED TRIAL I
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Mt Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials